about
Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry.Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpuraBilateral periorbital ecchymoses. An often missed sign of amyloid purpura.Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura.Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismThe splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs.Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies.[Thrombotic thrombocytopenic purpura--an often missed diagnosis].High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence.Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research StudyPlasma DNA is Elevated in Patients with Deep Vein ThrombosisAssociation between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study.Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes.Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2.Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?May-Thurner syndrome: missed diagnosis and missed early treatment?Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation.Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism.Opana ER-induced thrombotic microangiopathy.Standardized Management Protocol in Severe Postpartum Hemorrhage: A Single-Center Study.Thrombotic thrombocytopenic purpuraScreening for lupus anticoagulant: improving the performance of the lupus-sensitive PTT-LARelapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without RituximabThe impact of congenital thrombotic thrombocytopenic purpura on pregnancy complicationsProspective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolismThe International Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at enrolment until 2017VWF and complementPearls, guidelines & morePatent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndromeHematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: Pathophysiology and Differentiation from Graft versus Host DiseaseRisk stratification of elderly patients with acute pulmonary embolismEnhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma
P50
Q33408029-5BE1239B-DDD7-4FD3-8668-BA0CF035A594Q33412520-3175A0AD-8F7D-4CD7-931D-128FFAF6866EQ33416165-563AF146-8596-4132-A948-B5CEF7B7BD38Q33416281-EF6BE865-6460-4BD4-AE5C-94AEB001782DQ33417203-F79B73EB-DE09-4846-9ACA-3C25B3D42122Q33417876-D750BF6F-E6BA-475B-867A-67C63FEBCD83Q33418811-1A2E628E-2DD3-4E31-A2CA-0D25EE5DD5E5Q33419625-54C7F542-6316-4AD4-9BA5-CDAEE27BCBB7Q33427539-714958E5-080F-4391-8ABE-053C1F7624F7Q33436972-B837617A-3DFC-4C56-8CB7-EFE86517A80DQ35932419-1C4E6186-4A32-408B-A9F0-FF2F1FE849D5Q37262537-274FB0D9-F218-4A05-8F40-E0F8A56FB707Q40054784-C2A7A4A3-1557-4F19-95FA-616F3A382FF6Q40506524-59F0E49D-8827-4339-8DAE-DDFB48AE741AQ41282310-36A97CBF-AE2E-42C8-9E2D-4D05C50BCBF4Q42197262-83D1AD48-1ACB-438C-8CAB-70D63B4D0334Q46357641-89F51DF6-5130-4CA8-A7A5-2374757C77D3Q47564368-9B759342-DC09-4F2A-A6A3-526E7DBBD458Q47826895-1E9BED4D-6F9B-45B7-B823-495E466A139EQ50140098-B01E703A-9502-42C4-A4ED-C3C2281ABAF2Q50284440-EBE967EA-7924-4420-8601-5F5E3EC6259EQ50496561-D508DE62-9405-4459-8EB1-EF3379346868Q52730791-1162E49B-E175-4E49-B65B-CFFB146B41D3Q53688959-2D52E9F6-AD3C-4BCC-BB76-8E79C9AEA1F3Q54222388-03330B46-8B11-46D8-B321-A9FED624D6E6Q57379903-636E3A56-E272-4FF1-9E2C-BDA8632E2109Q57591146-53EF67A9-3B0E-4225-8A01-6234734E5DABQ58708963-F39135CB-3358-483F-B4B6-6F0214DD3698Q59567000-17E334DA-79EA-4469-9137-CAC8D263A37EQ62383709-9F4FF6E0-8E3E-4625-AAC9-31865646CE1FQ64040361-88D412D1-4A10-472D-A336-9BD1013EE862Q86672483-DABE8795-9969-4321-845A-04AE2C69E54EQ87498979-F8FFCAF1-B424-4F9A-BC6D-2FDA6010B608Q91167225-20DDDC53-0AAD-4516-AA44-76BFCE64078CQ93040781-CAE8624A-A725-4A4C-850B-80E90853CE3EQ93071525-DC1CC289-6C89-472E-AE8D-E36FEE43487FQ93540848-7F653057-7485-43CF-AA38-D37A7B5EE6C2
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Bernhard Lämmle
@en
Bernhard Lämmle
@nl
type
label
Bernhard Lämmle
@en
Bernhard Lämmle
@nl
prefLabel
Bernhard Lämmle
@en
Bernhard Lämmle
@nl
P31
P496
0000-0003-4538-5154